[{"id":"d95b6e0f-bd31-40e1-a7d4-92b5c93e57e2","acronym":"","url":"https://clinicaltrials.gov/study/NCT06043817","created_at":"2023-09-21T15:10:32.135Z","updated_at":"2024-07-02T16:35:08.774Z","phase":"Phase 1/2","brief_title":"First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations","source_id_and_acronym":"NCT06043817","lead_sponsor":"Scorpion Therapeutics, Inc.","biomarkers":" EGFR","pipe":" | ","alterations":" EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e STX-721"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 09/26/2023","start_date":" 09/26/2023","primary_txt":" Primary completion: 06/01/2027","primary_completion_date":" 06/01/2027","study_txt":" Completion: 06/01/2028","study_completion_date":" 06/01/2028","last_update_posted":"2024-04-18"}]